What are the consensus estimates for ETHOS TECHNOLOGIES INC CL-A (LIFE) next earnings?
The consensus EPS estimate for the next earnings of ETHOS TECHNOLOGIES INC CL-A (LIFE) is -1 USD and the consensus revenue estimate is 147.94M USD.
ETHOS TECHNOLOGIES INC CL-A (LIFE) Forecast, Price Target & Analyst Ratings
NASDAQ:LIFE • US29765A1016
Current stock price
10.93 USD
+0.13 (+1.2%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ETHOS TECHNOLOGIES INC CL-A (LIFE).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q1 / 2026
- EPS Estimate
- -$1.00
- Revenue Estimate
- 147.94M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $10.93 to mean target of N/A, Based on 13 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
8.85%
3 Months
10.15%
Price Target Summary
The average price target has been revised upward by 10.15% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.15%
LIFE was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about LIFE.
In the previous month the buy percentage consensus was at a similar level.
LIFE was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-24 | Deutsche Bank | Initiate | Buy |
| 2026-02-23 | Citizens | Initiate | Market Outperform |
| 2026-02-23 | William Blair | Initiate | Outperform |
| 2026-02-23 | Barclays | Initiate | Overweight |
| 2026-02-23 | JP Morgan | Initiate | Overweight |
| 2026-02-23 | Baird | Initiate | Outperform |
| 2026-02-23 | Goldman Sachs | Initiate | Buy |
| 2026-02-23 | B of A Securities | Initiate | Buy |
| 2026-02-23 | Citigroup | Initiate | Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-05 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-10 | RBC Capital | Reiterate | Outperform |
| 2023-04-11 | Piper Sandler | Maintains | Overweight |
| 2023-03-10 | RBC Capital | Reiterate | Outperform |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q1 / 2026
- EPS Estimate
- -$1.00
- Revenue Estimate
- 147.94M
- Revenue Q2Q
- N/A
- EPS Q2Q
- -291.85%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-6.98%
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 10.386M | 353K -96.60% | 338.64K -4.07% | 393.05M 115,967.21% | 521.99M 32.80% | 644.1M 23.39% | 386.67M -39.97% | 527.66M 36.46% | 753.26M 42.75% | 990.03M 31.43% | |
| EBITDA YoY % growth | -33.54M -118.64% | -46.172M -37.66% | -54.327M -17.66% | -73.134M -34.62% | 88.839M 221.47% | 103.24M 16.21% | 138.59M 34.24% | 174.98M 26.26% | 171.26M -2.13% | 281.52M 64.38% | 395.76M 40.58% | |
| EBIT YoY % growth | -34.015M -113.80% | -46.404M -36.42% | -54.919M -18.35% | -66.588M -21.25% | -59.287M 10.96% | -2.257M 96.19% | 54.173M 2,500.22% | 228.29M 321.41% | 352.81M 54.54% | 549.58M 55.77% | 799.19M 45.42% | |
| Operating Margin | N/A | -446.79% | -15,557.79% | -19,663.25% | -15.08% | -0.43% | 8.41% | 59.04% | 66.86% | 72.96% | 80.72% | |
| EPS YoY % growth | -1.88 -18.24% | -1.60 14.89% | -0.96 40.00% | -0.94 2.52% | 1.39 248.01% | -0.16 -111.37% | 1.29 918.39% | 2.39 85.50% | 4.01 67.88% | 6.41 59.72% | 8.69 35.56% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -1.00 -291.85% | 0.21 177.69% |
| Revenue Q2Q % growth | 147.94M | 116.34M |
| EBITDA Q2Q % growth | 32.057M | 20.356M |
| EBIT Q2Q % growth | -128.641M -630.62% | 1.581M 108.54% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ETHOS TECHNOLOGIES INC CL-A / LIFE Forecast FAQ
What is the consensus rating for LIFE stock?
The consensus rating for ETHOS TECHNOLOGIES INC CL-A (LIFE) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.